Psoriasis Clinical Trial

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

Summary

This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will be collected during the first 3 weeks of the study; safety and efficacy data will be collected for the 8 weeks of the treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of chronic plaque psoriasis
10 - 35% BSA of involved skin
Age 12 - 17

Exclusion Criteria:

Other type of psoriasis (other than plaque)
Significant abnormal lab findings
Vit D insufficiency

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

25

Study ID:

NCT00419666

Recruitment Status:

Completed

Sponsor:

Galderma R&D

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Dermatology Research of Arkansas
Little Rock Arkansas, 72205, United States
Children's Hospital, Department of Pediatric and Adolescent Dermatology
San Diego California, 92123, United States
Dermatology Center For Children & Young Adults
Eagan Minnesota, 55121, United States
University of Texas-Houston Medical Center Dept of Dermatology
Houston Texas, 77030, United States
Center for Clinical Studies
Webster Texas, 77598, United States
Nexus Clinical Research
St. John's Newfoundland and Labrador, A1B 3, Canada
Newlab Clinical Research, Inc.
St. John's Newfoundland and Labrador, A1C 2, Canada

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

25

Study ID:

NCT00419666

Recruitment Status:

Completed

Sponsor:


Galderma R&D

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider